Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia - Ottmann, Oliver G.; Krämer, Alwin; Bochtler, Tilmann (British journal of haematology, 2019)